HempNewsBreaks

TuesdayJan 02, 2018 9:44 am

HempNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Adds Dr. Brian O’Connor to Advisory Board

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced the addition of Dr. Brian O’Connor, a consultant in respiratory medicine, to its advisory board. Per the update, O’Connor is a clinical expert in the areas of asthma, chronic obstructive pulmonary disease (“COPD”), allergic disease and lung cancer. He is also an active clinical researcher committed to investigating new treatment strategies in airways disease. “Dr. O’Connor brings a great reputation of clinical excellence and scholarly research,” Dr. Lui Franciosi, CEO of Veritas, stated in the news release. “He will advise us on…

Continue Reading

FridayDec 29, 2017 12:05 pm

HempNewsBreaks – Skinvisible, Inc. (SKVI) Prepares to Address Killer Drug Epidemic Through Proposed Merger Agreement

Topical and transdermal product development company Skinvisible (OTCQB: SKVI) recently signed a letter of intent regarding a proposed merger with Quoin Pharmaceuticals Limited. The two companies intend to work together to address the opioid epidemic plaguing America. An article discussing this reads: “There are increased incentives and growing public and FDA/government demands to address the crisis. Innovators vying to meet critical needs and to combat the opioid issue with alternative, non-addictive and effective products include Skinvisible, Inc. (OTCQB: SKVI) and Quoin Pharmaceuticals Limited. As announced earlier this month, the two companies have entered a Letter of Intent for a proposed…

Continue Reading

FridayDec 29, 2017 11:57 am

HempNewsBreaks – Marijuana Company of America, Inc. (MCOA) Positioned for Bright Future Amid Support from Recognized Health Organization

With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) is slated to exploit the ever-growing cannabis market as support of the industry continues to grow among recognized health organizations. An article discussing this reads: “The World Health Organization (“WHO”) officially recommended on December 14, 2017, that the chemical compound cannabidiol (CBD) no longer be internationally scheduled as a controlled substance. WHO has issued a preliminary report that found CBD to be non-addictive and generally safe. ... The wholly-owned subsidiary of Marijuana Company of America Inc. (OTC: MCOA), hempSMART™, Inc. is an affiliate marketing…

Continue Reading

FridayDec 29, 2017 9:44 am

HempNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Visits Clinical Trial Facility in San Juan, Puerto Rico

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced that it has completed a prestudy visit of the Fundación de Investigación (“FDI”) facilities in San Juan, Puerto Rico. Per the release, this will be the site where the company’s research arm, Cannevert Therapeutics Ltd. (“CTL”), will be conducting its first human study of CTL-X, a cannabis strain targeting the pain management market. Speaking about the FDI clinical trial facility in this morning's update, Veritas CEO Lui Franciosi stated, “I was very impressed by their Phase I and Phase II-III clinical trial…

Continue Reading

ThursdayDec 28, 2017 11:29 am

HempNewsBreaks – AppSwarm, Inc. (SWRM) Has Finger on Pulse of Burgeoning Mobile Gaming Industry

As gaming, and mobile gaming in particular, approaches an expected $110 billion in revenues worldwide this year, developer and publisher AppSwarm (OTC: SWRM) is working to incubate new talent as it acquires apps for all mobile devices. The company also announced the development of a joint roll-out of mobile applications for the purchase of cannabis using bitcoin payment options and blockchain technology, in conjunction with SinglePoint, Inc. (OTC: SING). Article discussing this reads: “The global gaming industry is expected to grow by almost eight percent over 2016 and to generate a total of approximately $110 billion in revenues this year,…

Continue Reading

ThursdayDec 28, 2017 10:16 am

HempNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Subsidiary Receives Dealer License from Health Canada

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced that Health Canada has issued its research and development subsidiary, Cannevert Therapeutics Ltd. (“CTL”), a dealer license allowing it to possess, analyze, sale, send, transport and deliver cannabis, hemp and related products. Per the release, reception of this license marks a “significant step” for CTL as it seeks to discover and develop new therapeutic cannabis strains while also providing commercial chemical and biological testing services for licensed producers under Health Canada guidelines. “We are excited that Cannevert scientists will now not only…

Continue Reading

WednesdayDec 27, 2017 12:16 pm

HempNewsBreaks – Medical Cannabis Payment Solutions (REFG) Serving Cannabis Industry with Merchant Processing Power

As attention grows in regard to the possibilities for a legal marketplace serving the varied needs of the medical and recreational marijuana industries, Medical Cannabis Payment Solutions (OTC: REFG) is positioning itself to compete in the industry verticals serving cannabis patients and corporate clients. An article discussing this reads: “In response to the need for a private encrypted digital solution, REFG is positioned in the industry as a first-tier merchant processing pioneer. REFG, through subsidiary StateSourced, has launched the first and only comprehensive card processing system of its kind. With considerable investment in market research and product development, the company…

Continue Reading

WednesdayDec 27, 2017 11:55 am

HempNewsBreaks – CNBC Publication Highlights SinglePoint, Inc.’s (SING) SingleSeed as Alternative for Cash-only Cannabis Industry

SinglePoint’s (OTC: SING) mobile app SingleSeed is gaining attention thanks to a CNBC article on its ability to help cannabis dispensaries and customers exchange funds through bitcoin. Using debit or credit cards, consumers can make purchases without the need to rely on conventional banks that may be reluctant to transact business with the cannabis industry amid ongoing controversy about federal drug policy. An article discussing this reads: “It was obvious banks didn’t want to handle legal marijuana transactions, … which meant cannabis retailers and consumers were forced to bring cash to the table, and it was apparent that an alternative…

Continue Reading

WednesdayDec 27, 2017 11:33 am

HempNewsBreaks – Global Payout, Inc. (GOHE) CEO Releases Letter to Shareholders

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced the release of a year-end letter to shareholders from CEO James Hancock. In the letter, Hancock recaps what he calls an “especially active, yet successful” year for both Global Payout and its majority-owned subsidiary, MoneyTrac Technology, Inc. In particular, he notes the company’s appointment of Vanessa Luna to the position of chief operating officer as a major milestone in Global Payout’s strategic plans. “Without question, one of the most critical events of the year involved the appointment of Ms. Vanessa Luna as Global's Chief Operating Officer,” Hancock stated in…

Continue Reading

TuesdayDec 26, 2017 12:44 pm

HempNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Set to Exploit the Cannabis Industry Utilizing Proprietary Technology

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is well positioned in the booming cannabis industry with its patent-protected technology, DehyraTECH™, which enables a more efficient delivery and absorption of cannabinoids. An article discussing this reads: “Lexaria research and development partnership with the Canadian government’s National Research Council underscores the significance of its unique technology. Results from the endeavor are expected to support accelerating B2B relationships – and not just in the booming cannabis and CBD/hemp oil industry. Much more can be done to enhance and enable delivery of active pharmaceutical ingredients in a wide variety of important health-related fields, offering Lexaria…

Continue Reading